692 results
Page 13 of 35
6-K
EX-99.1
mk378w3
19 Jun 12
More Than 15 Clinical, Pre-Clinical and Health Economics Studies Will Be Presented
12:00am
6-K
EX-99.1
4xx0ivd38rfmkkg
1 Jun 12
Teva Pharmaceutical Industries Ltd. Chairman of the Board Dr. Phillip Frost Purchases 1 Million Teva Shares
12:00am
6-K
EX-99.1
n85904qr2tt071t2
24 May 12
Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40
12:00am
6-K
EX-99.1
0tsbdz
23 May 12
Live Filing
12:00am
6-K
EX-99.1
y0tl92l185
17 May 12
Teva’s Board of Directors Votes to Re-Elect Dr. Phillip Frost as Chairman of the Board
12:00am
6-K
n76uk4gw
9 May 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
j6e6bd8uanhb xq5kyz
9 May 12
Current report (foreign)
12:00am
6-K
EX-99.1
1v69xacr1n
8 May 12
Teva Appoints Michael Hayden as President of Global Research and Development and Chief Scientific Officer
12:00am
6-K
EX-99.1
7ckg hi2q
8 May 12
Live Filing
12:00am
6-K
EX-99.1
js1nfu5ne82bbwy5
1 May 12
Live Filing
12:00am
6-K
EX-99.1
5kt87 ejd0wr
27 Apr 12
Live Filing
12:00am
CORRESP
j0sgci3ilsv3
23 Apr 12
Correspondence with SEC
12:00am
6-K
EX-99.1
eqpef
20 Apr 12
Teva Announces Pricing of EUR 1 Billion and CHF 450 Million of Senior Notes, and the Closing of a New JPY 100 Billion Unsecured Syndicated Facility
12:00am
6-K
EX-99.1
7m9bo6xsapsgi87o4tdy
18 Apr 12
Teva Announces New Data on Central Nervous System Products to Be Presented at 2012 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
zc3kw
5 Apr 12
Live Filing
12:00am
6-K
EX-99.1
0gpwto
4 Apr 12
Teva Provides Litigation Update
12:00am
6-K
EX-99.1
9f4 ux1y70bvusalk7
28 Mar 12
Teva Announces Launch of Generic Seroquel® in the United States
12:00am
6-K
EX-99.1
j616o l9kb
21 Mar 12
Live Filing
12:00am
6-K
EX-99.1
2ykhcy
16 Mar 12
Live Filing
12:00am
6-K
EX-99.1
eostd81y35 40s
14 Mar 12
Teva Announces Launch of Generic Lexapro® in the United States; Awarded 180-Day Period of Marketing Exclusivity
12:00am